The latest update to Teva Pharmaceutical Industries' narrative centers on a modestly higher fair value estimate, now at US$37.95 per share compared with the prior US$36.77, reflecting how recent ...

During 2025, the dry bulk market witnessed increased market volatility, mainly due to geopolitical reasons. In the fourth quarter of 2025, we achieved $0.14 of adjusted earnings per share, and our ...

EUR/USD’s latest rally looks to be taking a breather just north of 1.1900. That area is acting as a bit of a ceiling for now, ...

Market focus shifts toward margin durability, pipeline momentum, and valuation stability within biotechnology peers. Neurocrine Biosciences (NASDAQ:NBIX) has entered renewed market focus after a ...

Nextdoor Holdings (NYSE: NXDR) released fourth-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to ...

Leaders Arsenal blow a 2-0 lead to draw at rock-bottom Wolves and miss the chance to go seven points clear at the top of the ...